SCHEMBL30168601

SCHEMBL30168601

CO/C=C(\Oc1cc(-c2ccccc2F)ccc1Cl)C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.40
ACMSD Q8TDX5 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 2/20 0.35
RORC P51449 1/20 0.35
MEN1 O00255 1/20 0.35
PTPRC P08575 1/20 0.35
PTPN1 P18031 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
ROCK2 O75116 2/20 0.34
ROCK1 Q13464 2/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23717590 1.00 ERN1 (0.40) ERN1ACMSDHDAC6ALDH1A1MAPT
SCHEMBL23706401 0.90 ERN1 (0.41) ERN1ACMSDHDAC6RORCPTPRC
SCHEMBL30168597 0.87 ERN1 (0.41) ERN1ACMSDHDAC6ALDH1A1MAPT
SCHEMBL23717628 0.87 ERN1 (0.41) ERN1ACMSDHDAC6ALDH1A1MAPT
SCHEMBL23717591 0.82 ERN1 (0.41) ERN1ACMSDHDAC6ALDH1A1MAPT
SCHEMBL23732043 0.78 ERN1 (0.43) ERN1ACMSDHDAC6ALDH1A1MAPT
SCHEMBL23706396 0.77 ERN1 (0.42) ERN1ACMSDHDAC6PTPRCPTPN1
SCHEMBL21675861 0.76 MCL1 (0.40) MAPTKMT2AMEN1CTSA
SCHEMBL8651351 0.75 ATP6AP1 (0.32) HDAC6MAPTKMT2A
SCHEMBL8651223 0.75 ATP6AP1 (0.32) HDAC6MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US claimed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US claimed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US claimed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US claimed
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US disclosed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US disclosed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD MT-CO3, MT-CO2, HADHB ERN1 3471/4885ACMSD 1317/4885HDAC6 3182/4885
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD FASTKD1, MT-CO1, MT-CO2 ERN1 3646/4885ACMSD 929/4885HDAC6 1676/4885
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD CYP51A1, CTRL, ERG28 ERN1 378/4885ACMSD 3020/4885HDAC6 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.